Related Experiment Videos

[Carcinoma of the cecum and appendicitis. Ultrasonographic diagnosis]

E Falco¹, G Celoria, R Stefani

¹II Divisione di Chirurgia Generale, Ospedale S. Andrea, La Spezia.

Minerva Chirurgica

|October 31, 1992

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Safety and efficacy of encorafenib-cetuximab combination in BRAF V600E -mutated metastatic colorectal cancer: real-world evidence from the CONFIDENCE Spanish multicenter study.

ESMO real world data and digital oncology·2026

Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer.

Gynecologic oncology·2023

A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2021

First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).

BMC cancer·2019

Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study.

European journal of cancer (Oxford, England : 1990)·2018

See all related articles